Search results
Results from the Health.Zone Content Network
History Early years. The company's origins go back to a Massachusetts real estate investment trust organized in 1969 as DMG, Inc. In 1978, DMG, Inc. was reorganized as a Florida corporation and changed its name to Diversified Mortgage Investors, Inc. DMG had been invested in retirement home developments when it was taken over by the Rales, and in 1984, the company adopted the name Danaher and ...
On February 28, 2018, Ackman exited his near billion-dollar bet against Herbalife after the company's stock price continued to rise. COVID-19 response. Ahead of the 2020 stock market crash, Ackman hedged Pershing Square's portfolio, investing $27 million to purchase credit protection, insuring the portfolio against steep market losses.
Pharmaceutical companies have increased list prices on 775 brand-name drugs so far in 2024, the Journal reported. They “generally attributed the price increases to market trends, inflation and ...
Headquartered in Leverkusen, Bayer's areas of business include: pharmaceuticals, consumer healthcare products, agricultural chemicals, seeds and biotechnology products. The company is a component of the EURO STOXX 50 stock market index.
List of largest biomedical companies by market capitalization. The following is a list of independent pharmaceutical, biotechnology and medical companies listed on a stock exchange (as indicated) with current market capitalization of at least US$10 billion, ranked by their market capitalization. It does not include biotechnology companies that ...
DMG Mori Co., Ltd. (DMG森精機株式会社, DMG Mori Seiki Kabushiki-gaisha) (formerly Mori Seiki Co., Ltd. and DMG Mori Seiki Co., Ltd.) is a Japanese company headquartered in Tokyo and Nara City, engaged primarily in the manufacture and sale of machine tools. [3] [4] [5] Since its establishment, the business has become the largest machine ...
In December 2016, 20 American attorneys general filed a civil complaint accusing Aurobindo Pharma of a coordinated scheme to artificially maintain high prices for a generic antibiotic and diabetes drug. The complaint alleged price collusion schemes between six pharmaceutical firms including informal gatherings, telephone calls, and text messages.
Formation of Amneal Pharmaceuticals Inc. In 2018, Amneal Pharmaceuticals LLC merged with Impax Laboratories, Inc. to form Amneal Pharmaceuticals, Inc. The FTC described the merger as having a value of US$1.45 billion, and required the companies to divest several marketed products and development projects as a condition of the approval.